Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_assertion type Assertion NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_head.
- NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_assertion description "[The phosphatidylinositol 3-kinase (PI3K)/AKT pathway has been implicated in the growth and survival of hematologic malignancies and inhibition of this pathway is considered as a therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_provenance.
- NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_assertion evidence source_evidence_literature NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_provenance.
- NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_assertion SIO_000772 16645590 NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_provenance.
- NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_assertion wasDerivedFrom befree-20140225 NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_provenance.
- NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_assertion wasGeneratedBy ECO_0000203 NP500065.RA382UgBLrk1gqlyW4hvbE_H7sGvnVnmlsEnR6tmlcefY130_provenance.